In severe asthma, benralizumab reduced daily oral glucocorticoid dose and asthma exacerbations at 6 months

Diego J. Maselli, Jay I. Peters

Research output: Contribution to journal › Comment/debate › peer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'In severe asthma, benralizumab reduced daily oral glucocorticoid dose and asthma exacerbations at 6 months'. Together they form a unique fingerprint.